[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Oliván-Viguera et al., 2020 - Google Patents

Minimally invasive system to reliably characterize ventricular electrophysiology from living donors

Oliván-Viguera et al., 2020

View HTML
Document ID
10002212596998945085
Author
Oliván-Viguera A
Pérez-Zabalza M
García-Mendívil L
Mountris K
Orós-Rodrigo S
Ramos-Marques E
Vallejo-Gil J
Fresneda-Roldán P
Fañanás-Mastral J
Vázquez-Sancho M
Matamala-Adell M
Sorribas-Berjón F
Bellido-Morales J
Mancebón-Sierra F
Vaca-Núñez A
Ballester-Cuenca C
Marigil M
Pastor C
Ordovás L
Köhler R
Diez E
Pueyo E
Publication year
Publication venue
Scientific reports

External Links

Snippet

Cardiac tissue slices preserve the heterogeneous structure and multicellularity of the myocardium and allow its functional characterization. However, access to human ventricular samples is scarce. We aim to demonstrate that slices from small transmural core biopsies …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases

Similar Documents

Publication Publication Date Title
Oliván-Viguera et al. Minimally invasive system to reliably characterize ventricular electrophysiology from living donors
Barriga et al. Tissue stiffening coordinates morphogenesis by triggering collective cell migration in vivo
O’Shea et al. ElectroMap: high-throughput open-source software for analysis and mapping of cardiac electrophysiology
Kang et al. Human organotypic cultured cardiac slices: new platform for high throughput preclinical human trials
Bensley et al. Three-dimensional direct measurement of cardiomyocyte volume, nuclearity, and ploidy in thick histological sections
Bernier-Latmani et al. High-resolution 3D analysis of mouse small-intestinal stroma
Bayliss et al. Chemical modulation of receptor signaling inhibits regenerative angiogenesis in adult zebrafish
Fox et al. Formaldehyde fixation.
Rust et al. A revised view on growth and remodeling in the retinal vasculature
Lapp et al. Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes
Ouni et al. A blueprint of the topology and mechanics of the human ovary for next-generation bioengineering and diagnosis
Sengle et al. A correlative method for imaging identical regions of samples by micro-CT, light microscopy, and electron microscopy: imaging adipose tissue in a model system
Raisch et al. Intercalated disk extracellular nanodomain expansion in patients with atrial fibrillation
Walsh et al. Functional optical imaging of primary human tumor organoids: development of a personalized drug screen
Wyles et al. Pharmacological modulation of calcium homeostasis in familial dilated cardiomyopathy: an in vitro analysis from an RBM20 patient‐derived iPSC model
Wang et al. UV fluorescence excitation imaging of healing of wounds in skin: evaluation of wound closure in organ culture model
Acker et al. EPSPs measured in proximal dendritic spines of cortical pyramidal neurons
Chowdhury et al. Concurrent micro-to macro-cardiac electrophysiology in myocyte cultures and human heart slices
Phang et al. A review of diabetic wound models—Novel insights into diabetic foot ulcer
Watson et al. A practical guide for investigating cardiac physiology using living myocardial slices
Cirillo et al. Nerve activity recordings in routine human intestinal biopsies
Myles et al. Effect of activation sequence on transmural patterns of repolarization and action potential duration in rabbit ventricular myocardium
Gibson et al. Coming to consensus: what defines deep partial thickness burn injuries in porcine models?
Uchida et al. Diffusional and electrical properties of T-tubules are governed by their constrictions and dilations
Sivaguru et al. Cardiac muscle organization revealed in 3-D by imaging whole-mount mouse hearts using two-photon fluorescence and confocal microscopy